These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3181045

  • 21. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P, Motolese M, Cerqua R, Mancini M.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
    McCrindle BW, Ose L, Marais AD.
    J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827
    [Abstract] [Full Text] [Related]

  • 23. Hyperlipoproteinemia: diagnosis and management.
    Shakir KM.
    Prim Care; 1976 Jun; 3(2):277-91. PubMed ID: 1047448
    [Abstract] [Full Text] [Related]

  • 24. [Dyslipidemias].
    Spoto S, Navajas Martinez MF, Costantino S.
    Clin Ter; 2003 Jun; 154(1):65-9. PubMed ID: 12854288
    [No Abstract] [Full Text] [Related]

  • 25. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W, Seifert A.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of hypolipemic agents on levels of total plasma homocysteine].
    Dvoráková J, Dubská L, Táborský L, Hyánek J.
    Vnitr Lek; 2001 Oct 01; 47(10):674-7. PubMed ID: 11789004
    [No Abstract] [Full Text] [Related]

  • 27. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A, Gennari C, Picchi M.
    Boll Soc Ital Biol Sper; 1974 Sep 15; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Management of dyslipidemia.
    Akel MM, Salti I.
    J Med Liban; 2001 Sep 15; 49(5):274-8. PubMed ID: 12243421
    [No Abstract] [Full Text] [Related]

  • 31. Managing hyperlipidaemia.
    Nestel PJ.
    Med J Aust; 1988 Jan 04; 148(1):29-31. PubMed ID: 3336296
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G, Cazzani E, Romanò M, Muzio L.
    Clin Ter; 1982 May 31; 101(4):387-93. PubMed ID: 7105643
    [No Abstract] [Full Text] [Related]

  • 35. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P, Bianchine JR.
    Am J Med Sci; 1969 Oct 31; 258(4):275-81. PubMed ID: 5823464
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 Oct 31; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G, Montini M, Simonutti M, Nosari I, Pagani G.
    Clin Ter; 1978 May 31; 85(4):361-73. PubMed ID: 668273
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.